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Abstract
Nowadays, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) or CoV disease of 2019 (COVID-19) 
infection is a big threat to global health and becomes a global pandemic. The exact treatment for this disease is still an 
on-going experiment. Meanwhile, there are more people infected by this disease, leading to severe acute respiratory 
syndrome (SARS). COVID-19 patients with severe clinical symptoms may need mechanical ventilation. These 
patients at the same time, struggle with the infection and also the effort to wean from the ventilation. Weaning failure 
commonly occurred in patients with severe respiratory disease. In this article, we discuss the use of convalescence 
plasma therapy and the benefit of music stimulation for weaning from mechanical ventilation in COVID-19 patients.
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Introduction
Since December 2019, the epidemic of SARS-
CoV-2 has rapidly spread worldwide. Originating in 
Wuhan, China, this disease has affected hundreds of 
nations within 4 months. The outbreak of SARS-CoV-2 
has become a major concern all over the world [1]. 
Pneumonia that induced by the SARS-CoV-2 is named 
CoV disease 2019 (COVID-19). As it has affected 
thousands of people, the World Health Organization 
has declared that this disease is a pandemic [2].
Lack of study and knowledge about further 
treatment has led to many deaths due to the severity 
of the symptom and comorbid. The efficacy of recent 
treatment is still on clinical evaluation and investigation, 
due to there are no approved specific antiviral agents, 
it is an urgent need to look for an alternative treatment 
strategy for COVID-19. In order to prevent death among 
the severe COVID-19 patients [3].
Severe pneumonia caused by human CoV was 
characterized by rapid viral replication, massive inflammatory 
cell infiltration, and elevated pro-inflammatory cytokines or 
even cytokine storm in alveoli of lungs, resulting in acute 
pulmonary injury and acute respiratory distress syndrome 
(ARDS). COVID-19 is a type III hypersensitivity reaction 
due to antigen-antibody immune complex deposition 
with complement activation [4], [5]. Recent studies on 
COVID-19 demonstrated that the lymphocyte counts in 
the peripheral blood were remarkably decreased and the 
levels of cytokines in the plasma from patients requiring 
intensive care unit (ICU) support, including interleukin (IL)-
6, IL-10, tumor necrosis factor (TNF)-α, and granulocyte-
macrophage colony-stimulating factor, were significantly 
higher than those who did not require ICU conditions [6], [7].
Recently, a Group of study regarding the use 
of convalescent plasma (CP) therapy as one of COVID-
19 treatment. Are still on going research and need to 
be tested tin severe COVID-19 patients. As we know, 
CP therapy is classic adaptive immunotherapy and 
has been applied as a treatment of many infectious 
diseases. This therapy has been acknowledged more 
than one century. In 2003, this therapy had been used 
as a treatment in SARS patients (n = 80) at Prince 
Wales Hospital, Hong Kong. It had been reported 
that this therapy demonstrated clinical deterioration 
despite treatment with methylprednisolone and most 
of the patients demonstrated good clinical outcome, 
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associated with there was no adverse effect reported 
during the plasma infusion [8], [9], [10].
In association of the clinical symptom severity 
and comorbid disease, there were many patients 
experience the need of mechanical ventilation. As many 
of the patients experience mechanical ventilation, most 
of patient having a difficulty in the effort of weaning 
from mechanical ventilation. This condition was 
believed related to the dysfunction of the brain during 
the ventilation. There is a complex interaction between 
lung and brain in critically ill patients who experienced 
mechanical ventilation. This review will discuss the 
effect of music stimulation in weaning from mechanical 
ventilation among COVID-19 patients.
CP Therapy for COVID 19
As we know, until now, there are still no 
approved specific antiviral agents for novel CoV 
disease. Many clinicians and scientists are trying to find 
an alternative treatment for severe COVID-19 patients, 
considering the mortality rate still increasing. CP or 
immunoglobulin is the last resort to improve clinical 
outcome and survival rate of patients SARS-CoV-2. This 
therapy known as classic adaptive immunotherapy and 
had been known for many infectious diseases more than 
one century. Driven by passive immunity driven bay CP 
can provide neutralizing antibodies (NAbs) that restrain 
the infection [11]. SARS-CoV 2 infection induces IgG 
antibodies production against nucleoprotein that can 
be detected at day 4 after the onset of disease and 
with seroconversion at day 14. Shen et al. showed that 
recovered donors from COVID-19 infection had specific 
antibody titers ranging between 1.800 and 16.200 and 
NAbs titers were between 80 and 480. The plasma 
obtained from the donors and transfused in the recipients 
on the same day leads to viral load decreased. The 
presence of NAbs in the recipients played a key role in 
the restriction of viral infections. This study showed that 
the titers of NAbs in patients infected with SARS-CoV-2 
were low before day 10 post-disease onset and then 
increased, with a peak 10–15 days after disease onset, 
remaining stable thereafter in all patients [12], [13].
This treatment had been recommended by 
WHO as an empirical treatment during the outbreak of 
Ebola virus in 2014. Moreover, it was also successfully 
used in the treatment of SARS, Middle East respiratory 
syndrome (MERS), and H1N1 pandemic in 2009 with 
good and satisfactory clinical outcomes and safety. This 
treatment associated with the condition of most patients 
of SARS-CoV-2 whose continue to deteriorate despite 
treatment with a corticosteroid. Although, according to 
WHO, the management of COVID-19 mainly focused 
on infection prevention, case detection and monitoring, 
and supportive care. Until now, May 2020, no specific 
treatment is recommended due to the lack of study and 
clinical evidence [14].
CP therapy was obtained from recovered 
patients who had established humoral immunity against 
the virus, contains a large quantity of NAbs of the virus, 
and eradicates the pathogen from blood circulation 
and pulmonary tissues. However, the CP therapy was 
unable to improve the survival in Ebola virus disease 
due to the absence of data of NAb titration for stratified 
analysis. Since the virological and clinical characteristics 
among MERS and SARS were similar to COVID-19, it 
is suggested that CP therapy might be an option for 
alternative treatment for COVID-19 patients. Patients 
who have recovered from COVID-19 with a high NAb 
titer may be a valuable donor source of CP [15].
This CP therapy had been applied for COVID-19 
patients in China on January 2020, with 10 participants of 
severe COVID-19 patients. This trial using one dose of 
200 ml CP transfusion was well tolerated. Among those 
patients, there are three patients received mechanical 
ventilation and the others received high flow and low-flow 
nasal cannula oxygenation. From this trial, after treatment 
with CP, two patients were weaned from mechanical 
ventilation to high-flow nasal cannula. Moreover, the 
clinical symptoms significantly improved within 3 days, 
followed by the rapid neutralization of viremia [16].
A case series by Shen et al., from January 2020 
to March 2020, evaluates the benefit of CP therapy 
in five critically ill patients with laboratory-confirmed 
COVID-19 and ARDS with severe pneumonia and 
mechanical ventilation. All five were treated with CP. 
This study suggested that viral load declined within 
days of treatment, and the clinical symptoms were 
improved. Among those patients, four of them who 
had been receiving mechanical ventilation and ECMO 
no longer required respiratory support after plasma 
transfusion [17].
Effort of Weaning from Mechanical 
Ventilation in COVID-19 Patients
In severe COVID-19 patients, most of the 
cases required critical care management, including 
mechanical ventilation. Mechanical ventilation is the 
most common life-sustaining therapy for COVID-19 
patients in ICU. It temporarily replaces spontaneous 
breathing in COVID-19 patients who suffered from 
respiratory failure [18].
Many patients who receive ventilator support 
are “fighting their ventilator” at some point of their 
therapy. This condition, referred to as “patient-ventilator 
asynchrony,” described the fact that a mechanically 
ventilated patient keeps a spontaneous respiratory 
activity and this activity is not in phase with the machine. 
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This usually happened during awakening from sedation 
or during ventilator weaning [19].
Weaning defined as the withdrawal of 
mechanical ventilation to re-establish spontaneous 
breathing. Weaning covers the entire process of 
liberating the patient from mechanical support and 
from the endotracheal tube. Weaning comprises 
40–50% of the total duration of mechanical ventilation. 
Approximately 70% of patients in intensive care 
successfully weaned without difficulty on the first 
attempt. While other patients experience more difficulty 
or prolonged period of weaning, this may lead to a 
poorer prognosis. Some issue was considered as the 
caused, but the most possible cause is the weakness 
or fatigue of the diaphragm and the accessory muscle 
of inspiration that leads to the failure of weaning from 
mechanical ventilation. Another cause is considered 
that mechanical ventilation affects the diaphragmatic 
structure and functions, known as ventilator-induced 
diaphragmatic dysfunction, related to the changes in 
myofiber length and rapid atrophy [20].
Long duration of bed rest and immobility in critical 
ill patients may result in profound physical deconditioning. 
These effects may be induced by inflammation, lack 
of glycemic control, and pharmacological agents. The 
incidence of skeletal muscle weakness in the ICU is 
observed in 25% of ventilated patients. Inspiratory 
muscle training is a technique that loads the diaphragm 
and accessory inspiratory muscle to improve strength 
and endurance [20].
During the pandemic of COVID-19, due to the 
severity of clinical symptoms can lead to respiratory 
failure, many patients required mechanical ventilation. 
Weaning from mechanical ventilation is very essential 
in the care of critically ill intubated patients, especially 
those who suffered from SARS-CoV-2. This process 
related to the entire process of liberating the patient from 
mechanical support and from the endotracheal tube, 
needs the involvement of the good function of the brain 
as well. Critically ill patients develop neuropsychological 
disturbance. Neurocognitive sequelae frequently 
occurred among critically ill patients [20].
Lung-brain Interactions in Mechanically 
Ventilated COVID-19 Patients
COVID-19 patients with severe clinical symptoms 
are associated with high morbidity and mortality rate. 
Those patients may require mechanical ventilation. 
Some of them survive the condition while others may 
not survive from this pandemic. Those patients who 
survive and still receive mechanical ventilation may 
suffer neuropsychological alterations such as memory 
impairment. Although mechanical ventilation is important 
life support for many critical patients, especially in COVID-
19 patients with a severe symptom, it is not without 
complication. It is intrinsically able to be worsening with 
possible spread to other organs, including the brain, and 
ultimately leading to multiorgan failure [21].
Studies described regarding mechanism 
implicated in lung-brain interaction during mechanical 
ventilation have been less investigated. It suggested 
that cognitive impairment seen in patients who 
received mechanical ventilation [22]. The etiology of 
these neurocognitive deficits is probably a multifactorial 
cause such as hypoxemia, the use of sedative and/or 
analgesics, hypotension, altered regulation of blood 
glucose levels, the duration of mechanical ventilation 
usage, the length of stay in the ICU, and the presence 
of confusional syndrome [23]. Many clinical studies 
had shown that mechanical ventilation may induce a 
biological response through infiltration of monocytes and 
macrophages, the release of mediator inflammation. 
This mechanism may lead to lung damage. Some 
studies also suggested that there is a relationship 
between hypoxia and hippocampal damage since 
hippocampus is the brain structure related to learning 
and memory capacity, it is also known to be vulnerable 
to hypoxia. There is also evidence that ARDS can 
induce structural alterations in the hippocampus. 
These studies support the existence of a brain-lung 
communication axis associated with the release of 
catecholamines, neurokinins, and neuropeptides [24].
During mechanical ventilation, the lung 
generates information through the stimulation of the 
mechanoreceptors or chemoreceptors, which reaches 
the central nervous system (CNS) through other routes. 
By this mechanism, the brain responds by altering the 
Figure 1. Interaction pathway between the lungs and central nervous 
system (CNS) during mechanical ventilation. The CNS receives 
information from the peripheral through three pathways: Humoral, 
neural, and cellular pathway [26], [27]
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permeability of the blood-brain-barrier or by modifying 
cerebral blood flow. Communication pathways between 
peripheral and CNS are illustrated in Figure 1. First 
pathway is the humoral pathway, through inflammatory 
mediators such as IL-6, TNF-α, and IL-1β, by the 
recruitment of peripheral monocytes or macrophages, 
may directly reach the brain [25].
COVID-19 infection, particularly, has a very close 
relation to respiratory distress since many of the patients 
suffer from respiratory failure and require mechanical 
ventilation. In COVID-19, patients who received mechanical 
ventilation considered to have a similar mechanism 
between lung and brain communication pathway during 
mechanical ventilation. An inadequate ventilation strategy 
may induce the release of certain inflammatory mediators 
or metabolites into the bloodstream, which can be 
detected by the CNS. An experimental study by Quilez et 
al. evaluated neuronal activation in a model of mechanical 
ventilation damage in rats. The lungs and brain share 
the same inflammatory mediators, and once these are 
released into the bloodstream, they can also make contact 
with the brain by interacting with specific CNS receptors. 
This mechanism involves an active transport mechanism 
which leads to the release of prostaglandin E2 and nitric 
oxide [24].
Possibility of Weaning Failure in COVID-
19 Patients
Weaning is an essential process, especially 
in severe COVID-19 patients who receive mechanical 
ventilation and involve a series of stages in the process of 
care. The weaning process involves a gradual decrease 
in ventilator settings as a patient’s respiratory status 
improves, leading to termination of mechanical ventilation 
support. For some patients, weaning may be difficult due to 
the patients cannot tolerate independent respirations when 
the artificial airway is removed [25]. Extubation failure is the 
inability to sustain spontaneous breathing after removal of 
the artificial airway with the need for re-intubation within 
24–72 h. The incidence rate of extubation failure is reported 
to be 26–42%. This failure associated with a high mortality 
rate. From a study by Coplin et al., the mortality rate was 
12% if there was no delay in extubation and 27% when 
extubation was delayed [28].
Music Stimulation during Mechanical 
Ventilation and Weaning in COVID-19 
Patients
To do a lifesaving intervention, one of the 
management is the initiation of mechanical ventilation 
to treat acute respiratory failure. This involved the 
administration of numerous sedative and analgesic 
medication which can prolong ventilation and increase 
the length of ICU stay [29]. As the patients recover from 
acute respiratory failure, they can be weaned from 
ventilator support. There are many factors associated 
with the success of weaning, such as respiratory 
muscle strength, adequate respiratory drive, acid-
base balance, neurological status, and psychological 
readiness [20]. Extubation failure can lead to ventilator-
associated pneumonia, airway trauma, increased costs, 
and higher mortality rates [30].
Some studies suggested than a number of 
non-pharmacological interventions have been shown to 
be an advantage for anxiety symptoms in ICU patients, 
this intervention such as music intervention. As we 
know, in ventilated patients, some of the patients may 
suffer anxiety during mechanical ventilation. Decreasing 
anxiety believed to be helpful in promoting ventilator 
weaning, especially in COVID-19 patients. Music is 
a non-pharmacological intervention that integrates 
physiological and psychological components to reduce 
stress and anxiety and ultimately promotes overall 
conditions [31], [32], [33].
A study held by Hunter et al. and Lee et al. had 
demonstrated that music is an effective complement in 
a certain condition of weaning difficulty by decreasing 
anxiety. The duration, frequency, and timing of music 
intervention approximately at least 30 min music-listening 
session once per day, from 1 day to up to 30 days. The 
following music programs were used as a preference: 
Western classical music, Chinese classical music (e.g., 
bamboo flute, rain, and tears), and music of natural 
sounds. All of the music had slow beat (60–80 beats/min) 
that corresponds to a normal heart rate and thought to be 
relaxing for the patients [32], [33], [34].
Conclusion
Based on our findings in this article, in severe 
and critically ill of COVID-19 patients, most patients 
urgently required mechanical ventilation. One of the 
problems regarding this management is the weaning 
failure from mechanical ventilation. Recently, many 
studies develop other treatment strategies for COVID-
19 patients. One of the effective treatments is CP 
therapy. In order to decrease the weaning failure rate in 
critically ill of COVID-19 patients, the author suggests 
the use of CP therapy priory the weaning process.
Regarding the possibility of weaning failure, 
we suggest to give music stimulation to decrease 
the psychological symptoms for patients undergoing 
mechanical ventilation. There are studies suggested 
that music intervention may lead to improve patients 
conditions and help to reduce patients’ anxiety levels. 
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These anxiety levels can be measured by indicators of 
blood pressure, heart rate, and respiration rate. Some 
study also measures the serum cortisol levels and 
stated that patients that received music intervention had 
lower serum cortisol levels. We hypothesize that due to 
the long duration of mechanical ventilation in COVID-
19 patients and the possibility of weaning failure, it 
may affect the hippocampal function and may lead to 
cognitive impairment in few years ahead. Further study 
regarding the effect after the long duration of mechanical 
ventilation in COVID-19 patients are required to be held, 
In order to prevent further cognitive deficits by among 
patients who had experienced mechanical ventilation. 
Developing an early screening of cognitive functions.
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